Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,956Revenue (TTM) $M997Net Margin (%)-21.3Altman Z-Score0.3
Enterprise Value $M3,242EPS (TTM) $-1.3Operating Margin %-22.6Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.7Pre-tax Margin (%)-32.0Higher ROA y-yN
Price/Book1.610-y EBITDA Growth Rate %--Quick Ratio1.5Cash flow > EarningsY
Price/Sales2.05-y EBITDA Growth Rate %--Current Ratio1.7Lower Leverage y-yN
Price/Free Cash Flow6.0y-y EBITDA Growth Rate %-91.6ROA % (ttm)-5.8Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-16.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M163ROIC % (ttm)-6.3Gross Margin Increase y-yN

Gurus Latest Trades with HZNP

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

HZNP is held by these investors:



HZNP: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
GREY MICHAEL GDirector 2017-05-10Buy10,000$9.4826.79view
Carey RobertEVP, Chief Business Officer 2017-03-01Sell31,808$16.03-25.02view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2016-08-02Sell2,900$20-39.9view
Nohria VirinderDirector 2016-06-15Sell25,000$17.69-32.05view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2016-02-26Sell4,100$20-39.9view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-12-10Sell4,456$20-39.9view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-09-21Sell7,750$31.78-62.18view
Watkins ThomasDirector 2015-08-19Buy10,000$31.32-61.62view
SHERMAN JEFFREY WEVP and Chief Medical Officer 2015-07-15Sell26,887$35.55-66.19view
Himawan JeffDirector 2015-03-13Sell554,564$22.44-46.43view

Press Releases about HZNP :

Quarterly/Annual Reports about HZNP:

News about HZNP:

Articles On GuruFocus.com
Uncovering Value in the Metals and Mining Sector Jun 26 2017 
Seeking Value in China: Great Wall Motor Jun 26 2017 
Vaccine Small-Cap Just Took a Big Step Forward Jun 26 2017 
Annaly Capital Management: Attractive 9.5% Dividend Yield, but Interest Rates Are a Major Risk Jun 25 2017 
Never a Better Time to Pile on Chipotle Jun 25 2017 
Oracle Slowly Gaining Momentum on the Cloud Front Jun 26 2017 
Boeing Takes Lead Over Airbus With $30 Billion Worth of Orders on Day 1 of Paris Air Show Jun 25 2017 
Berkshire Hathaway’s Recent Investment: Home Capital Group Jun 25 2017 
Stocks That Fell to 3-Year Lows in the Week of June 23 Jun 24 2017 
Weekly Top Insider Buys Highlight for the Week of June 23 Jun 24 2017 

More From Other Websites
3 Cheap Healthcare Stocks You Can Buy Right Now Jun 26 2017
Horizon Pharma plc Completes Sale of European Marketing Rights for PROCYSBI® (cysteamine... Jun 23 2017
Horizon Pharma plc Partners with Global Genes® to Unite the Rare Disease Community at the... Jun 20 2017
Horizon Pharma Gets Health Canada Approval for Procysbi Jun 20 2017
Horizon Pharma plc Announces Health Canada Approval of PROCYSBI™ (Cysteamine Delayed-Release... Jun 19 2017
Valeant: Stop Looking in the Rearview Mirror! Jun 16 2017
Horizon Pharma plc Presents New Data Analyses Further Demonstrating Clinical Benefit of KRYSTEXXA®... Jun 14 2017
Epidemiologic Study Findings Show Over 400 Percent Increase in Gout Patient Hospitalizations Since... Jun 14 2017
Horizon Pharma (HZNP) Up 11.3% Since Earnings Report: Can It Continue? Jun 12 2017
3 Value Stocks You Probably Haven't Considered Jun 08 2017
Falling Earnings Estimates Signal Weakness Ahead for Horizon Pharma (HZNP) May 31 2017
ETFs with exposure to Horizon Pharma Plc : May 26, 2017 May 26 2017
5 Stocks Setting Up for Big Breakouts May 26 2017
Horizon Pharma plc to Participate in Upcoming Conferences May 26 2017
Horizon Pharma plc Named One of the Best Workplaces in Chicago by Fortune May 25 2017
Horizon (HZNP) Sells European Rights for Procysbi & Quinsair May 25 2017
Horizon Pharma plc Announces Agreement to Sell European Marketing Rights to PROCYSBI® (cysteamine... May 23 2017
Julian Robertson's Tiger Mgmt Sold Apple and Google, Bought Adobe in Q1 May 22 2017
Nuvo Pharmaceuticals™ Inc. Announces Topline Results from European Ankle Sprain Study with... May 15 2017
Nuvo Pharmaceuticals™ Announces District Court Decision to Uphold U.S. Pennsaid® 2% Patent May 15 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}